nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP1A1—head and neck cancer	0.394	1	CbGaD
Sildenafil—ABCC5—Fluorouracil—head and neck cancer	0.155	0.318	CbGbCtD
Sildenafil—ABCC10—Docetaxel—head and neck cancer	0.118	0.243	CbGbCtD
Sildenafil—ABCC4—Fluorouracil—head and neck cancer	0.0745	0.153	CbGbCtD
Sildenafil—CYP2D6—Hydroxyurea—head and neck cancer	0.0356	0.073	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—head and neck cancer	0.0226	0.0463	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0226	0.0463	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—head and neck cancer	0.0169	0.0347	CbGbCtD
Sildenafil—CYP2C9—Fluorouracil—head and neck cancer	0.0149	0.0305	CbGbCtD
Sildenafil—CYP2D6—Vinblastine—head and neck cancer	0.0126	0.0258	CbGbCtD
Sildenafil—CYP3A4—Vinblastine—head and neck cancer	0.00802	0.0164	CbGbCtD
Sildenafil—CYP3A4—Docetaxel—head and neck cancer	0.00661	0.0135	CbGbCtD
Sildenafil—Rhinorrhoea—Docetaxel—head and neck cancer	0.000467	0.00485	CcSEcCtD
Sildenafil—Depression—Vinblastine—head and neck cancer	0.000446	0.00462	CcSEcCtD
Sildenafil—Eye irritation—Docetaxel—head and neck cancer	0.000443	0.0046	CcSEcCtD
Sildenafil—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000441	0.00457	CcSEcCtD
Sildenafil—Myocardial infarction—Vinblastine—head and neck cancer	0.000438	0.00454	CcSEcCtD
Sildenafil—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000438	0.00454	CcSEcCtD
Sildenafil—Swelling—Fluorouracil—head and neck cancer	0.000432	0.00448	CcSEcCtD
Sildenafil—Bone disorder—Docetaxel—head and neck cancer	0.000419	0.00435	CcSEcCtD
Sildenafil—Weight increased—Hydroxyurea—head and neck cancer	0.000416	0.00432	CcSEcCtD
Sildenafil—Lacrimation increased—Docetaxel—head and neck cancer	0.000411	0.00426	CcSEcCtD
Sildenafil—Infestation NOS—Hydroxyurea—head and neck cancer	0.000408	0.00423	CcSEcCtD
Sildenafil—Infestation—Hydroxyurea—head and neck cancer	0.000408	0.00423	CcSEcCtD
Sildenafil—Haemoglobin—Vinblastine—head and neck cancer	0.000403	0.00418	CcSEcCtD
Sildenafil—Haemorrhage—Vinblastine—head and neck cancer	0.000401	0.00416	CcSEcCtD
Sildenafil—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0004	0.00414	CcSEcCtD
Sildenafil—Hypoaesthesia—Vinblastine—head and neck cancer	0.000399	0.00414	CcSEcCtD
Sildenafil—Pharyngitis—Vinblastine—head and neck cancer	0.000398	0.00413	CcSEcCtD
Sildenafil—Hearing impaired—Docetaxel—head and neck cancer	0.000398	0.00413	CcSEcCtD
Sildenafil—Stomatitis—Hydroxyurea—head and neck cancer	0.000397	0.00412	CcSEcCtD
Sildenafil—Bone pain—Docetaxel—head and neck cancer	0.000395	0.0041	CcSEcCtD
Sildenafil—Cardiac failure—Fluorouracil—head and neck cancer	0.00039	0.00405	CcSEcCtD
Sildenafil—Osteoarthritis—Fluorouracil—head and neck cancer	0.000381	0.00395	CcSEcCtD
Sildenafil—Haemoglobin—Hydroxyurea—head and neck cancer	0.000368	0.00381	CcSEcCtD
Sildenafil—Haemorrhage—Hydroxyurea—head and neck cancer	0.000366	0.0038	CcSEcCtD
Sildenafil—Colitis—Docetaxel—head and neck cancer	0.000364	0.00377	CcSEcCtD
Sildenafil—Irritability—Fluorouracil—head and neck cancer	0.000363	0.00377	CcSEcCtD
Sildenafil—Cardiac arrest—Fluorouracil—head and neck cancer	0.000362	0.00376	CcSEcCtD
Sildenafil—Fluid retention—Docetaxel—head and neck cancer	0.000359	0.00373	CcSEcCtD
Sildenafil—Ataxia—Fluorouracil—head and neck cancer	0.000358	0.00371	CcSEcCtD
Sildenafil—Neuropathy—Docetaxel—head and neck cancer	0.000355	0.00369	CcSEcCtD
Sildenafil—Alopecia—Vinblastine—head and neck cancer	0.000355	0.00368	CcSEcCtD
Sildenafil—Oesophagitis—Docetaxel—head and neck cancer	0.000346	0.00359	CcSEcCtD
Sildenafil—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000341	0.00353	CcSEcCtD
Sildenafil—Muscular weakness—Fluorouracil—head and neck cancer	0.000336	0.00348	CcSEcCtD
Sildenafil—Angiopathy—Hydroxyurea—head and neck cancer	0.000332	0.00344	CcSEcCtD
Sildenafil—Dysphagia—Fluorouracil—head and neck cancer	0.000329	0.00341	CcSEcCtD
Sildenafil—Chills—Hydroxyurea—head and neck cancer	0.000328	0.00341	CcSEcCtD
Sildenafil—Ill-defined disorder—Vinblastine—head and neck cancer	0.000324	0.00336	CcSEcCtD
Sildenafil—Alopecia—Hydroxyurea—head and neck cancer	0.000323	0.00335	CcSEcCtD
Sildenafil—Anaemia—Vinblastine—head and neck cancer	0.000323	0.00335	CcSEcCtD
Sildenafil—Angina pectoris—Fluorouracil—head and neck cancer	0.000321	0.00332	CcSEcCtD
Sildenafil—Erythema—Hydroxyurea—head and neck cancer	0.000319	0.0033	CcSEcCtD
Sildenafil—Malaise—Vinblastine—head and neck cancer	0.000315	0.00327	CcSEcCtD
Sildenafil—Vertigo—Vinblastine—head and neck cancer	0.000314	0.00326	CcSEcCtD
Sildenafil—Leukopenia—Vinblastine—head and neck cancer	0.000313	0.00324	CcSEcCtD
Sildenafil—Swelling—Docetaxel—head and neck cancer	0.000312	0.00323	CcSEcCtD
Sildenafil—Deafness—Docetaxel—head and neck cancer	0.000307	0.00319	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000306	0.00317	CcSEcCtD
Sildenafil—Convulsion—Vinblastine—head and neck cancer	0.000303	0.00314	CcSEcCtD
Sildenafil—Hypertension—Vinblastine—head and neck cancer	0.000302	0.00313	CcSEcCtD
Sildenafil—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0003	0.00312	CcSEcCtD
Sildenafil—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000296	0.00307	CcSEcCtD
Sildenafil—Pneumonia—Fluorouracil—head and neck cancer	0.000295	0.00306	CcSEcCtD
Sildenafil—Anaemia—Hydroxyurea—head and neck cancer	0.000294	0.00305	CcSEcCtD
Sildenafil—Discomfort—Vinblastine—head and neck cancer	0.000294	0.00305	CcSEcCtD
Sildenafil—Hot flush—Docetaxel—head and neck cancer	0.000294	0.00305	CcSEcCtD
Sildenafil—Infestation NOS—Fluorouracil—head and neck cancer	0.000293	0.00304	CcSEcCtD
Sildenafil—Infestation—Fluorouracil—head and neck cancer	0.000293	0.00304	CcSEcCtD
Sildenafil—Menopausal symptoms—Docetaxel—head and neck cancer	0.000291	0.00302	CcSEcCtD
Sildenafil—Atrial fibrillation—Docetaxel—head and neck cancer	0.00029	0.00301	CcSEcCtD
Sildenafil—Visual disturbance—Docetaxel—head and neck cancer	0.00029	0.00301	CcSEcCtD
Sildenafil—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000289	0.003	CcSEcCtD
Sildenafil—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000288	0.00298	CcSEcCtD
Sildenafil—Myocardial infarction—Fluorouracil—head and neck cancer	0.000288	0.00298	CcSEcCtD
Sildenafil—Malaise—Hydroxyurea—head and neck cancer	0.000287	0.00298	CcSEcCtD
Sildenafil—Stomatitis—Fluorouracil—head and neck cancer	0.000286	0.00297	CcSEcCtD
Sildenafil—Urinary tract infection—Fluorouracil—head and neck cancer	0.000285	0.00296	CcSEcCtD
Sildenafil—Conjunctivitis—Fluorouracil—head and neck cancer	0.000285	0.00296	CcSEcCtD
Sildenafil—Leukopenia—Hydroxyurea—head and neck cancer	0.000285	0.00296	CcSEcCtD
Sildenafil—Cardiac failure—Docetaxel—head and neck cancer	0.000282	0.00292	CcSEcCtD
Sildenafil—Epistaxis—Fluorouracil—head and neck cancer	0.000277	0.00287	CcSEcCtD
Sildenafil—Convulsion—Hydroxyurea—head and neck cancer	0.000276	0.00286	CcSEcCtD
Sildenafil—Sinusitis—Fluorouracil—head and neck cancer	0.000275	0.00286	CcSEcCtD
Sildenafil—Pain in extremity—Docetaxel—head and neck cancer	0.000275	0.00285	CcSEcCtD
Sildenafil—Anorexia—Vinblastine—head and neck cancer	0.000272	0.00282	CcSEcCtD
Sildenafil—Migraine—Docetaxel—head and neck cancer	0.000271	0.00281	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000269	0.00279	CcSEcCtD
Sildenafil—Discomfort—Hydroxyurea—head and neck cancer	0.000268	0.00278	CcSEcCtD
Sildenafil—Haemoglobin—Fluorouracil—head and neck cancer	0.000265	0.00275	CcSEcCtD
Sildenafil—Rhinitis—Fluorouracil—head and neck cancer	0.000264	0.00274	CcSEcCtD
Sildenafil—Haemorrhage—Fluorouracil—head and neck cancer	0.000263	0.00273	CcSEcCtD
Sildenafil—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000262	0.00272	CcSEcCtD
Sildenafil—Pharyngitis—Fluorouracil—head and neck cancer	0.000261	0.00271	CcSEcCtD
Sildenafil—Oedema—Hydroxyurea—head and neck cancer	0.00026	0.0027	CcSEcCtD
Sildenafil—Ataxia—Docetaxel—head and neck cancer	0.000258	0.00268	CcSEcCtD
Sildenafil—Infection—Hydroxyurea—head and neck cancer	0.000258	0.00268	CcSEcCtD
Sildenafil—Paraesthesia—Vinblastine—head and neck cancer	0.000256	0.00266	CcSEcCtD
Sildenafil—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000255	0.00264	CcSEcCtD
Sildenafil—Liver function test abnormal—Docetaxel—head and neck cancer	0.000254	0.00263	CcSEcCtD
Sildenafil—Skin disorder—Hydroxyurea—head and neck cancer	0.000253	0.00262	CcSEcCtD
Sildenafil—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000251	0.0026	CcSEcCtD
Sildenafil—Abdominal pain upper—Docetaxel—head and neck cancer	0.000251	0.0026	CcSEcCtD
Sildenafil—Breast disorder—Docetaxel—head and neck cancer	0.000248	0.00258	CcSEcCtD
Sildenafil—Anorexia—Hydroxyurea—head and neck cancer	0.000248	0.00257	CcSEcCtD
Sildenafil—Decreased appetite—Vinblastine—head and neck cancer	0.000248	0.00257	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000247	0.00257	CcSEcCtD
Sildenafil—Nasopharyngitis—Docetaxel—head and neck cancer	0.000246	0.00255	CcSEcCtD
Sildenafil—Constipation—Vinblastine—head and neck cancer	0.000244	0.00253	CcSEcCtD
Sildenafil—Pain—Vinblastine—head and neck cancer	0.000244	0.00253	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000242	0.00251	CcSEcCtD
Sildenafil—Dysphagia—Docetaxel—head and neck cancer	0.000238	0.00246	CcSEcCtD
Sildenafil—Arrhythmia—Fluorouracil—head and neck cancer	0.000235	0.00244	CcSEcCtD
Sildenafil—Feeling abnormal—Vinblastine—head and neck cancer	0.000235	0.00244	CcSEcCtD
Sildenafil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000233	0.00242	CcSEcCtD
Sildenafil—Alopecia—Fluorouracil—head and neck cancer	0.000233	0.00241	CcSEcCtD
Sildenafil—Dyspnoea—Hydroxyurea—head and neck cancer	0.000232	0.0024	CcSEcCtD
Sildenafil—Angina pectoris—Docetaxel—head and neck cancer	0.000231	0.0024	CcSEcCtD
Sildenafil—Somnolence—Hydroxyurea—head and neck cancer	0.000231	0.0024	CcSEcCtD
Sildenafil—Erythema—Fluorouracil—head and neck cancer	0.000229	0.00238	CcSEcCtD
Sildenafil—Dyspepsia—Hydroxyurea—head and neck cancer	0.000229	0.00237	CcSEcCtD
Sildenafil—Decreased appetite—Hydroxyurea—head and neck cancer	0.000226	0.00234	CcSEcCtD
Sildenafil—Abdominal pain—Vinblastine—head and neck cancer	0.000225	0.00234	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000224	0.00233	CcSEcCtD
Sildenafil—Fatigue—Hydroxyurea—head and neck cancer	0.000224	0.00232	CcSEcCtD
Sildenafil—Pain—Hydroxyurea—head and neck cancer	0.000222	0.00231	CcSEcCtD
Sildenafil—Constipation—Hydroxyurea—head and neck cancer	0.000222	0.00231	CcSEcCtD
Sildenafil—Weight increased—Docetaxel—head and neck cancer	0.000216	0.00224	CcSEcCtD
Sildenafil—Vision blurred—Fluorouracil—head and neck cancer	0.000216	0.00224	CcSEcCtD
Sildenafil—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000214	0.00222	CcSEcCtD
Sildenafil—Pneumonia—Docetaxel—head and neck cancer	0.000213	0.00221	CcSEcCtD
Sildenafil—Anaemia—Fluorouracil—head and neck cancer	0.000212	0.0022	CcSEcCtD
Sildenafil—Infestation—Docetaxel—head and neck cancer	0.000212	0.0022	CcSEcCtD
Sildenafil—Infestation NOS—Docetaxel—head and neck cancer	0.000212	0.0022	CcSEcCtD
Sildenafil—PDE6C—head—head and neck cancer	0.000212	0.114	CbGeAlD
Sildenafil—Hypersensitivity—Vinblastine—head and neck cancer	0.00021	0.00218	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00021	0.00218	CcSEcCtD
Sildenafil—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000209	0.00217	CcSEcCtD
Sildenafil—Renal failure—Docetaxel—head and neck cancer	0.000208	0.00216	CcSEcCtD
Sildenafil—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000208	0.00215	CcSEcCtD
Sildenafil—Myocardial infarction—Docetaxel—head and neck cancer	0.000208	0.00215	CcSEcCtD
Sildenafil—Stomatitis—Docetaxel—head and neck cancer	0.000206	0.00214	CcSEcCtD
Sildenafil—Conjunctivitis—Docetaxel—head and neck cancer	0.000206	0.00214	CcSEcCtD
Sildenafil—Body temperature increased—Hydroxyurea—head and neck cancer	0.000206	0.00213	CcSEcCtD
Sildenafil—Leukopenia—Fluorouracil—head and neck cancer	0.000205	0.00213	CcSEcCtD
Sildenafil—Asthenia—Vinblastine—head and neck cancer	0.000205	0.00212	CcSEcCtD
Sildenafil—Epistaxis—Docetaxel—head and neck cancer	0.0002	0.00207	CcSEcCtD
Sildenafil—Convulsion—Fluorouracil—head and neck cancer	0.000199	0.00206	CcSEcCtD
Sildenafil—Myalgia—Fluorouracil—head and neck cancer	0.000195	0.00202	CcSEcCtD
Sildenafil—Chest pain—Fluorouracil—head and neck cancer	0.000195	0.00202	CcSEcCtD
Sildenafil—Diarrhoea—Vinblastine—head and neck cancer	0.000195	0.00202	CcSEcCtD
Sildenafil—Discomfort—Fluorouracil—head and neck cancer	0.000193	0.002	CcSEcCtD
Sildenafil—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000192	0.00199	CcSEcCtD
Sildenafil—Haemoglobin—Docetaxel—head and neck cancer	0.000191	0.00198	CcSEcCtD
Sildenafil—Rhinitis—Docetaxel—head and neck cancer	0.000191	0.00198	CcSEcCtD
Sildenafil—Haemorrhage—Docetaxel—head and neck cancer	0.00019	0.00197	CcSEcCtD
Sildenafil—Hypoaesthesia—Docetaxel—head and neck cancer	0.000189	0.00196	CcSEcCtD
Sildenafil—Pharyngitis—Docetaxel—head and neck cancer	0.000189	0.00196	CcSEcCtD
Sildenafil—Dizziness—Vinblastine—head and neck cancer	0.000189	0.00196	CcSEcCtD
Sildenafil—Urinary tract disorder—Docetaxel—head and neck cancer	0.000188	0.00195	CcSEcCtD
Sildenafil—Oedema peripheral—Docetaxel—head and neck cancer	0.000187	0.00194	CcSEcCtD
Sildenafil—Oedema—Fluorouracil—head and neck cancer	0.000187	0.00194	CcSEcCtD
Sildenafil—Connective tissue disorder—Docetaxel—head and neck cancer	0.000187	0.00194	CcSEcCtD
Sildenafil—Asthenia—Hydroxyurea—head and neck cancer	0.000187	0.00193	CcSEcCtD
Sildenafil—Urethral disorder—Docetaxel—head and neck cancer	0.000186	0.00193	CcSEcCtD
Sildenafil—Infection—Fluorouracil—head and neck cancer	0.000186	0.00193	CcSEcCtD
Sildenafil—Nervous system disorder—Fluorouracil—head and neck cancer	0.000184	0.0019	CcSEcCtD
Sildenafil—Visual impairment—Docetaxel—head and neck cancer	0.000183	0.0019	CcSEcCtD
Sildenafil—Tachycardia—Fluorouracil—head and neck cancer	0.000183	0.00189	CcSEcCtD
Sildenafil—Vomiting—Vinblastine—head and neck cancer	0.000181	0.00188	CcSEcCtD
Sildenafil—Erythema multiforme—Docetaxel—head and neck cancer	0.00018	0.00186	CcSEcCtD
Sildenafil—Headache—Vinblastine—head and neck cancer	0.000179	0.00185	CcSEcCtD
Sildenafil—Anorexia—Fluorouracil—head and neck cancer	0.000178	0.00185	CcSEcCtD
Sildenafil—Diarrhoea—Hydroxyurea—head and neck cancer	0.000178	0.00185	CcSEcCtD
Sildenafil—Eye disorder—Docetaxel—head and neck cancer	0.000178	0.00184	CcSEcCtD
Sildenafil—Flushing—Docetaxel—head and neck cancer	0.000176	0.00183	CcSEcCtD
Sildenafil—Cardiac disorder—Docetaxel—head and neck cancer	0.000176	0.00183	CcSEcCtD
Sildenafil—Hypotension—Fluorouracil—head and neck cancer	0.000175	0.00181	CcSEcCtD
Sildenafil—Angiopathy—Docetaxel—head and neck cancer	0.000173	0.00179	CcSEcCtD
Sildenafil—Dizziness—Hydroxyurea—head and neck cancer	0.000172	0.00178	CcSEcCtD
Sildenafil—Immune system disorder—Docetaxel—head and neck cancer	0.000172	0.00178	CcSEcCtD
Sildenafil—Mediastinal disorder—Docetaxel—head and neck cancer	0.000171	0.00178	CcSEcCtD
Sildenafil—Chills—Docetaxel—head and neck cancer	0.000171	0.00177	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000171	0.00177	CcSEcCtD
Sildenafil—Arrhythmia—Docetaxel—head and neck cancer	0.00017	0.00176	CcSEcCtD
Sildenafil—Nausea—Vinblastine—head and neck cancer	0.000169	0.00176	CcSEcCtD
Sildenafil—Insomnia—Fluorouracil—head and neck cancer	0.000169	0.00176	CcSEcCtD
Sildenafil—Paraesthesia—Fluorouracil—head and neck cancer	0.000168	0.00174	CcSEcCtD
Sildenafil—Alopecia—Docetaxel—head and neck cancer	0.000168	0.00174	CcSEcCtD
Sildenafil—Dyspnoea—Fluorouracil—head and neck cancer	0.000167	0.00173	CcSEcCtD
Sildenafil—Mental disorder—Docetaxel—head and neck cancer	0.000167	0.00173	CcSEcCtD
Sildenafil—Somnolence—Fluorouracil—head and neck cancer	0.000166	0.00173	CcSEcCtD
Sildenafil—Erythema—Docetaxel—head and neck cancer	0.000166	0.00172	CcSEcCtD
Sildenafil—Malnutrition—Docetaxel—head and neck cancer	0.000166	0.00172	CcSEcCtD
Sildenafil—Vomiting—Hydroxyurea—head and neck cancer	0.000165	0.00171	CcSEcCtD
Sildenafil—Dyspepsia—Fluorouracil—head and neck cancer	0.000165	0.00171	CcSEcCtD
Sildenafil—Rash—Hydroxyurea—head and neck cancer	0.000164	0.0017	CcSEcCtD
Sildenafil—Dermatitis—Hydroxyurea—head and neck cancer	0.000164	0.0017	CcSEcCtD
Sildenafil—Headache—Hydroxyurea—head and neck cancer	0.000163	0.00169	CcSEcCtD
Sildenafil—Decreased appetite—Fluorouracil—head and neck cancer	0.000163	0.00169	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000162	0.00168	CcSEcCtD
Sildenafil—Back pain—Docetaxel—head and neck cancer	0.00016	0.00166	CcSEcCtD
Sildenafil—Pain—Fluorouracil—head and neck cancer	0.00016	0.00166	CcSEcCtD
Sildenafil—Nausea—Hydroxyurea—head and neck cancer	0.000154	0.0016	CcSEcCtD
Sildenafil—Feeling abnormal—Fluorouracil—head and neck cancer	0.000154	0.0016	CcSEcCtD
Sildenafil—ABCC5—hair follicle—head and neck cancer	0.000153	0.0826	CbGeAlD
Sildenafil—Anaemia—Docetaxel—head and neck cancer	0.000153	0.00159	CcSEcCtD
Sildenafil—Urticaria—Fluorouracil—head and neck cancer	0.000149	0.00154	CcSEcCtD
Sildenafil—Syncope—Docetaxel—head and neck cancer	0.000148	0.00154	CcSEcCtD
Sildenafil—Leukopenia—Docetaxel—head and neck cancer	0.000148	0.00154	CcSEcCtD
Sildenafil—Body temperature increased—Fluorouracil—head and neck cancer	0.000148	0.00153	CcSEcCtD
Sildenafil—Palpitations—Docetaxel—head and neck cancer	0.000146	0.00152	CcSEcCtD
Sildenafil—Loss of consciousness—Docetaxel—head and neck cancer	0.000145	0.00151	CcSEcCtD
Sildenafil—Cough—Docetaxel—head and neck cancer	0.000144	0.0015	CcSEcCtD
Sildenafil—Convulsion—Docetaxel—head and neck cancer	0.000143	0.00149	CcSEcCtD
Sildenafil—Hypertension—Docetaxel—head and neck cancer	0.000143	0.00148	CcSEcCtD
Sildenafil—Arthralgia—Docetaxel—head and neck cancer	0.000141	0.00146	CcSEcCtD
Sildenafil—Chest pain—Docetaxel—head and neck cancer	0.000141	0.00146	CcSEcCtD
Sildenafil—Myalgia—Docetaxel—head and neck cancer	0.000141	0.00146	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00014	0.00145	CcSEcCtD
Sildenafil—Hypersensitivity—Fluorouracil—head and neck cancer	0.000138	0.00143	CcSEcCtD
Sildenafil—Dry mouth—Docetaxel—head and neck cancer	0.000138	0.00143	CcSEcCtD
Sildenafil—Oedema—Docetaxel—head and neck cancer	0.000135	0.0014	CcSEcCtD
Sildenafil—Infection—Docetaxel—head and neck cancer	0.000134	0.00139	CcSEcCtD
Sildenafil—Shock—Docetaxel—head and neck cancer	0.000133	0.00138	CcSEcCtD
Sildenafil—Nervous system disorder—Docetaxel—head and neck cancer	0.000132	0.00137	CcSEcCtD
Sildenafil—Pruritus—Fluorouracil—head and neck cancer	0.000132	0.00137	CcSEcCtD
Sildenafil—Tachycardia—Docetaxel—head and neck cancer	0.000132	0.00137	CcSEcCtD
Sildenafil—Skin disorder—Docetaxel—head and neck cancer	0.000131	0.00136	CcSEcCtD
Sildenafil—Anorexia—Docetaxel—head and neck cancer	0.000129	0.00134	CcSEcCtD
Sildenafil—Diarrhoea—Fluorouracil—head and neck cancer	0.000128	0.00133	CcSEcCtD
Sildenafil—Hypotension—Docetaxel—head and neck cancer	0.000126	0.00131	CcSEcCtD
Sildenafil—PDE6H—head—head and neck cancer	0.000125	0.0672	CbGeAlD
Sildenafil—Dizziness—Fluorouracil—head and neck cancer	0.000124	0.00128	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000123	0.00128	CcSEcCtD
Sildenafil—Insomnia—Docetaxel—head and neck cancer	0.000122	0.00127	CcSEcCtD
Sildenafil—Paraesthesia—Docetaxel—head and neck cancer	0.000121	0.00126	CcSEcCtD
Sildenafil—Dyspnoea—Docetaxel—head and neck cancer	0.00012	0.00125	CcSEcCtD
Sildenafil—PDE6G—head—head and neck cancer	0.00012	0.0647	CbGeAlD
Sildenafil—Somnolence—Docetaxel—head and neck cancer	0.00012	0.00125	CcSEcCtD
Sildenafil—Vomiting—Fluorouracil—head and neck cancer	0.000119	0.00123	CcSEcCtD
Sildenafil—Dyspepsia—Docetaxel—head and neck cancer	0.000119	0.00123	CcSEcCtD
Sildenafil—Rash—Fluorouracil—head and neck cancer	0.000118	0.00122	CcSEcCtD
Sildenafil—Dermatitis—Fluorouracil—head and neck cancer	0.000118	0.00122	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—head and neck cancer	0.000117	0.00122	CcSEcCtD
Sildenafil—Headache—Fluorouracil—head and neck cancer	0.000117	0.00122	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000117	0.00121	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—head and neck cancer	0.000116	0.00121	CcSEcCtD
Sildenafil—Constipation—Docetaxel—head and neck cancer	0.000116	0.0012	CcSEcCtD
Sildenafil—Pain—Docetaxel—head and neck cancer	0.000116	0.0012	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—head and neck cancer	0.000111	0.00115	CcSEcCtD
Sildenafil—Nausea—Fluorouracil—head and neck cancer	0.000111	0.00115	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00011	0.00115	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—head and neck cancer	0.000107	0.00111	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—head and neck cancer	0.000107	0.00111	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—head and neck cancer	9.95e-05	0.00103	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—head and neck cancer	9.69e-05	0.00101	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—head and neck cancer	9.56e-05	0.000991	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—head and neck cancer	9.24e-05	0.000959	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—head and neck cancer	8.93e-05	0.000926	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—head and neck cancer	8.59e-05	0.000891	CcSEcCtD
Sildenafil—Rash—Docetaxel—head and neck cancer	8.52e-05	0.000883	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—head and neck cancer	8.51e-05	0.000883	CcSEcCtD
Sildenafil—Headache—Docetaxel—head and neck cancer	8.46e-05	0.000878	CcSEcCtD
Sildenafil—PDE6G—lymph node—head and neck cancer	8.41e-05	0.0453	CbGeAlD
Sildenafil—PDE5A—connective tissue—head and neck cancer	8.06e-05	0.0434	CbGeAlD
Sildenafil—Nausea—Docetaxel—head and neck cancer	8.02e-05	0.000832	CcSEcCtD
Sildenafil—PDE5A—epithelium—head and neck cancer	7.65e-05	0.0412	CbGeAlD
Sildenafil—ABCC10—parotid gland—head and neck cancer	7e-05	0.0377	CbGeAlD
Sildenafil—ABCC10—saliva-secreting gland—head and neck cancer	6.7e-05	0.0361	CbGeAlD
Sildenafil—ADORA2A—lymphoid tissue—head and neck cancer	6.47e-05	0.0349	CbGeAlD
Sildenafil—CYP1A1—mouth—head and neck cancer	5.59e-05	0.0301	CbGeAlD
Sildenafil—PDE5A—thyroid gland—head and neck cancer	5.35e-05	0.0288	CbGeAlD
Sildenafil—ADORA2A—head—head and neck cancer	5.21e-05	0.0281	CbGeAlD
Sildenafil—ABCC10—trachea—head and neck cancer	5.17e-05	0.0279	CbGeAlD
Sildenafil—ABCC5—thyroid gland—head and neck cancer	4.89e-05	0.0264	CbGeAlD
Sildenafil—PDE5A—head—head and neck cancer	4.75e-05	0.0256	CbGeAlD
Sildenafil—ABCC10—lymphoid tissue—head and neck cancer	4.5e-05	0.0243	CbGeAlD
Sildenafil—ABCC10—thyroid gland—head and neck cancer	4.09e-05	0.022	CbGeAlD
Sildenafil—CYP1A1—parotid gland—head and neck cancer	3.89e-05	0.021	CbGeAlD
Sildenafil—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	3.65e-05	0.00185	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	3.64e-05	0.00185	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—NAT2—head and neck cancer	3.51e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	3.5e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	3.5e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	3.48e-05	0.00177	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—PTEN—head and neck cancer	3.48e-05	0.00177	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—NAT2—head and neck cancer	3.47e-05	0.00177	CbGpPWpGaD
Sildenafil—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	3.46e-05	0.00176	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	3.45e-05	0.00175	CbGpPWpGaD
Sildenafil—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	3.44e-05	0.00175	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	3.42e-05	0.00174	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—VEGFA—head and neck cancer	3.42e-05	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—head and neck cancer	3.41e-05	0.00173	CbGpPWpGaD
Sildenafil—ABCC4—thyroid gland—head and neck cancer	3.39e-05	0.0183	CbGeAlD
Sildenafil—PDE5A—lymph node—head and neck cancer	3.32e-05	0.0179	CbGeAlD
Sildenafil—PDE6G—Signaling by Wnt—AKT1—head and neck cancer	3.26e-05	0.00166	CbGpPWpGaD
Sildenafil—CYP1A1—epithelium—head and neck cancer	3.25e-05	0.0175	CbGeAlD
Sildenafil—PDE5A—Hemostasis—MAPK3—head and neck cancer	3.24e-05	0.00165	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	3.21e-05	0.00163	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—UROD—head and neck cancer	3.08e-05	0.00157	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—MAPK1—head and neck cancer	3.08e-05	0.00157	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—UROD—head and neck cancer	3.08e-05	0.00156	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—DPYD—head and neck cancer	3.08e-05	0.00156	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.06e-05	0.00156	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—head and neck cancer	3.05e-05	0.00155	CbGpPWpGaD
Sildenafil—ABCC5—lymph node—head and neck cancer	3.04e-05	0.0164	CbGeAlD
Sildenafil—ABCC4—head—head and neck cancer	3.01e-05	0.0162	CbGeAlD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	3e-05	0.00153	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—YAP1—head and neck cancer	2.92e-05	0.00148	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—head and neck cancer	2.91e-05	0.00148	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NOTCH1—head and neck cancer	2.91e-05	0.00148	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—UROD—head and neck cancer	2.91e-05	0.00148	CbGpPWpGaD
Sildenafil—CYP1A1—trachea—head and neck cancer	2.87e-05	0.0155	CbGeAlD
Sildenafil—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	2.85e-05	0.00145	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	2.81e-05	0.00143	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	2.77e-05	0.00141	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	2.77e-05	0.00141	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KISS1—head and neck cancer	2.73e-05	0.00139	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	2.7e-05	0.00138	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—PIK3CA—head and neck cancer	2.67e-05	0.00136	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	2.67e-05	0.00136	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	2.62e-05	0.00133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PTEN—head and neck cancer	2.62e-05	0.00133	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	2.6e-05	0.00132	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	2.59e-05	0.00132	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—head and neck cancer	2.59e-05	0.00132	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	2.56e-05	0.0013	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	2.55e-05	0.0013	CbGpPWpGaD
Sildenafil—ABCC10—lymph node—head and neck cancer	2.54e-05	0.0137	CbGeAlD
Sildenafil—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	2.49e-05	0.00127	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—HRAS—head and neck cancer	2.47e-05	0.00126	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	2.47e-05	0.00125	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	2.45e-05	0.00125	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	2.43e-05	0.00124	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	2.41e-05	0.00123	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	2.4e-05	0.00122	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—UROD—head and neck cancer	2.38e-05	0.00121	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—head and neck cancer	2.37e-05	0.00121	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—STAT3—head and neck cancer	2.34e-05	0.00119	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	2.3e-05	0.00117	CbGpPWpGaD
Sildenafil—CYP2E1—lymphoid tissue—head and neck cancer	2.28e-05	0.0123	CbGeAlD
Sildenafil—CYP1A1—thyroid gland—head and neck cancer	2.27e-05	0.0122	CbGeAlD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.25e-05	0.00115	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GRP—head and neck cancer	2.25e-05	0.00114	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—MAPK3—head and neck cancer	2.24e-05	0.00114	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	2.22e-05	0.00113	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—UROD—head and neck cancer	2.19e-05	0.00111	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—AKT1—head and neck cancer	2.18e-05	0.00111	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT6—head and neck cancer	2.18e-05	0.00111	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—UROD—head and neck cancer	2.17e-05	0.0011	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTGS2—head and neck cancer	2.16e-05	0.0011	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—MAPK1—head and neck cancer	2.13e-05	0.00108	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—EGFR—head and neck cancer	2.13e-05	0.00108	CbGpPWpGaD
Sildenafil—ABCC4—lymph node—head and neck cancer	2.11e-05	0.0114	CbGeAlD
Sildenafil—CYP2E1—thyroid gland—head and neck cancer	2.07e-05	0.0112	CbGeAlD
Sildenafil—PDE6G—Signaling Pathways—NOTCH1—head and neck cancer	2.04e-05	0.00104	CbGpPWpGaD
Sildenafil—CYP1A1—head—head and neck cancer	2.02e-05	0.0109	CbGeAlD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.99e-05	0.00101	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	1.96e-05	0.000999	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—YAP1—head and neck cancer	1.93e-05	0.000981	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTEN—head and neck cancer	1.88e-05	0.000958	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PIK3CA—head and neck cancer	1.85e-05	0.000941	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.84e-05	0.000939	CbGpPWpGaD
Sildenafil—CYP2E1—head—head and neck cancer	1.84e-05	0.00991	CbGeAlD
Sildenafil—CYP3A7—Metabolism—NAT2—head and neck cancer	1.77e-05	0.000899	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—TYMS—head and neck cancer	1.75e-05	0.000891	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTM1—head and neck cancer	1.73e-05	0.000881	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.71e-05	0.000872	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—HRAS—head and neck cancer	1.71e-05	0.00087	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.69e-05	0.00086	CbGpPWpGaD
Sildenafil—PDE6G—Disease—STAT3—head and neck cancer	1.68e-05	0.000857	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.68e-05	0.000856	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GPX1—head and neck cancer	1.66e-05	0.000844	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CYP1A1—head and neck cancer	1.64e-05	0.000835	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.63e-05	0.000828	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.63e-05	0.000827	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MAPK3—head and neck cancer	1.61e-05	0.000819	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.6e-05	0.000816	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NOTCH1—head and neck cancer	1.57e-05	0.000799	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—DPYD—head and neck cancer	1.55e-05	0.000788	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IL2—head and neck cancer	1.55e-05	0.000787	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MAPK1—head and neck cancer	1.53e-05	0.000779	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EGFR—head and neck cancer	1.53e-05	0.000779	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—AKT1—head and neck cancer	1.51e-05	0.000768	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—YAP1—head and neck cancer	1.47e-05	0.000748	CbGpPWpGaD
Sildenafil—CYP2D6—head—head and neck cancer	1.46e-05	0.00785	CbGeAlD
Sildenafil—CYP3A4—Metabolism—UROD—head and neck cancer	1.43e-05	0.000728	CbGpPWpGaD
Sildenafil—CYP1A1—lymph node—head and neck cancer	1.41e-05	0.00761	CbGeAlD
Sildenafil—PDE6G—Signaling Pathways—IL2—head and neck cancer	1.4e-05	0.000713	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCND1—head and neck cancer	1.37e-05	0.000695	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PIK3CA—head and neck cancer	1.33e-05	0.000676	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTEN—head and neck cancer	1.32e-05	0.000671	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—head and neck cancer	1.32e-05	0.000669	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.28e-05	0.000652	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NAT2—head and neck cancer	1.28e-05	0.000651	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NAT2—head and neck cancer	1.28e-05	0.00065	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK3—head and neck cancer	1.24e-05	0.000633	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—head and neck cancer	1.23e-05	0.000625	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NAT2—head and neck cancer	1.21e-05	0.000614	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	0.000606	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK1—head and neck cancer	1.18e-05	0.000602	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	0.0006	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—head and neck cancer	1.17e-05	0.000593	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK3—head and neck cancer	1.13e-05	0.000573	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—DPYD—head and neck cancer	1.12e-05	0.000571	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—DPYD—head and neck cancer	1.12e-05	0.00057	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2—head and neck cancer	1.12e-05	0.000567	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—head and neck cancer	1.09e-05	0.000552	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	0.000545	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	0.000545	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—YAP1—head and neck cancer	1.06e-05	0.000542	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—YAP1—head and neck cancer	1.06e-05	0.000541	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DPYD—head and neck cancer	1.06e-05	0.000538	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.05e-05	0.000534	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.04e-05	0.000528	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—head and neck cancer	1.03e-05	0.000523	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—head and neck cancer	1.02e-05	0.000517	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2—head and neck cancer	1.01e-05	0.000515	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—YAP1—head and neck cancer	1e-05	0.000511	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—head and neck cancer	9.94e-06	0.000505	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NAT2—head and neck cancer	9.87e-06	0.000502	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—head and neck cancer	9.77e-06	0.000497	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.56e-06	0.000486	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—head and neck cancer	9.5e-06	0.000483	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.47e-06	0.000482	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—head and neck cancer	9.3e-06	0.000473	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—head and neck cancer	9.09e-06	0.000463	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NAT2—head and neck cancer	9.08e-06	0.000462	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NAT2—head and neck cancer	9e-06	0.000458	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—head and neck cancer	9e-06	0.000458	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TYMS—head and neck cancer	8.83e-06	0.000449	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTM1—head and neck cancer	8.73e-06	0.000444	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOTCH1—head and neck cancer	8.69e-06	0.000442	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK3—head and neck cancer	8.69e-06	0.000442	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DPYD—head and neck cancer	8.66e-06	0.000441	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—head and neck cancer	8.61e-06	0.000438	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—head and neck cancer	8.52e-06	0.000433	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—head and neck cancer	8.39e-06	0.000427	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GPX1—head and neck cancer	8.36e-06	0.000425	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1A1—head and neck cancer	8.27e-06	0.000421	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK1—head and neck cancer	8.27e-06	0.000421	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—head and neck cancer	8.27e-06	0.00042	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—YAP1—head and neck cancer	8.22e-06	0.000418	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK3—head and neck cancer	8.14e-06	0.000414	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DPYD—head and neck cancer	7.96e-06	0.000405	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DPYD—head and neck cancer	7.9e-06	0.000402	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK1—head and neck cancer	7.75e-06	0.000394	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—head and neck cancer	7.75e-06	0.000394	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—head and neck cancer	7.6e-06	0.000387	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—YAP1—head and neck cancer	7.56e-06	0.000384	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.54e-06	0.000384	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—YAP1—head and neck cancer	7.49e-06	0.000381	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	7.4e-06	0.000377	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—head and neck cancer	7.17e-06	0.000365	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—head and neck cancer	6.72e-06	0.000342	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—head and neck cancer	6.64e-06	0.000338	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.58e-06	0.000335	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TYMS—head and neck cancer	6.4e-06	0.000325	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TYMS—head and neck cancer	6.38e-06	0.000325	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—head and neck cancer	6.32e-06	0.000322	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—head and neck cancer	6.31e-06	0.000321	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—head and neck cancer	6.22e-06	0.000316	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.17e-06	0.000314	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPX1—head and neck cancer	6.05e-06	0.000308	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—head and neck cancer	6.05e-06	0.000308	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPX1—head and neck cancer	6.04e-06	0.000307	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—head and neck cancer	6.03e-06	0.000307	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—head and neck cancer	6.01e-06	0.000306	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—head and neck cancer	5.99e-06	0.000305	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—head and neck cancer	5.98e-06	0.000304	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—head and neck cancer	5.98e-06	0.000304	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—head and neck cancer	5.96e-06	0.000303	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NAT2—head and neck cancer	5.94e-06	0.000302	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—head and neck cancer	5.86e-06	0.000298	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—head and neck cancer	5.83e-06	0.000297	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPX1—head and neck cancer	5.71e-06	0.00029	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.63e-06	0.000286	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—head and neck cancer	5.63e-06	0.000286	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—head and neck cancer	5.49e-06	0.000279	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.38e-06	0.000274	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DPYD—head and neck cancer	5.21e-06	0.000265	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—head and neck cancer	5.08e-06	0.000259	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—head and neck cancer	5.03e-06	0.000256	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—YAP1—head and neck cancer	4.94e-06	0.000251	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—head and neck cancer	4.93e-06	0.000251	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—head and neck cancer	4.92e-06	0.00025	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.91e-06	0.00025	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—head and neck cancer	4.91e-06	0.00025	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—head and neck cancer	4.88e-06	0.000248	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—head and neck cancer	4.81e-06	0.000245	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPX1—head and neck cancer	4.67e-06	0.000238	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.64e-06	0.000236	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—head and neck cancer	4.62e-06	0.000235	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK1—head and neck cancer	4.58e-06	0.000233	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—head and neck cancer	4.58e-06	0.000233	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—head and neck cancer	4.54e-06	0.000231	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—head and neck cancer	4.5e-06	0.000229	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—head and neck cancer	4.49e-06	0.000228	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.45e-06	0.000226	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPX1—head and neck cancer	4.3e-06	0.000219	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—head and neck cancer	4.29e-06	0.000218	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPX1—head and neck cancer	4.26e-06	0.000217	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—head and neck cancer	4.25e-06	0.000216	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.22e-06	0.000214	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—head and neck cancer	3.97e-06	0.000202	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—head and neck cancer	3.84e-06	0.000195	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.8e-06	0.000193	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—head and neck cancer	3.67e-06	0.000187	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—head and neck cancer	3.56e-06	0.000181	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—head and neck cancer	3.56e-06	0.000181	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.46e-06	0.000176	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—head and neck cancer	3.36e-06	0.000171	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—head and neck cancer	3.24e-06	0.000165	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—head and neck cancer	3.11e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—head and neck cancer	3.1e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—head and neck cancer	3.03e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—head and neck cancer	2.97e-06	0.000151	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.93e-06	0.000149	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—head and neck cancer	2.93e-06	0.000149	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX1—head and neck cancer	2.81e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.78e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.75e-06	0.00014	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.53e-06	0.000129	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.51e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—head and neck cancer	2.47e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—head and neck cancer	2.4e-06	0.000122	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—head and neck cancer	2.21e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—head and neck cancer	2.19e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.19e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—head and neck cancer	2.19e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.07e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—head and neck cancer	1.79e-06	9.11e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—head and neck cancer	1.79e-06	9.09e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.69e-06	8.61e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—head and neck cancer	1.69e-06	8.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.65e-06	8.41e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.56e-06	7.92e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.54e-06	7.85e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—head and neck cancer	1.44e-06	7.34e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—head and neck cancer	1.38e-06	7.03e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—head and neck cancer	1.27e-06	6.47e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—head and neck cancer	1.26e-06	6.41e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.02e-06	5.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—head and neck cancer	8.31e-07	4.23e-05	CbGpPWpGaD
